Stem Cells in Neurodegenerative Diseases

Stem cells have the potential to develop into many different types of cells in the body and may be useful as a therapy for several diseases including neurodegenerative diseases. Discover the latest research on stem cells and neurodegenerative diseases here.

September 18, 2020
Review

Towards a computational psychiatry of juvenile obsessive-compulsive disorder

Neuroscience and Biobehavioral Reviews
Alisa M Loosen, Tobias U Hauser
September 18, 2020

Reduced levels of serum vitamin B12 in symptomatic cases of oral lichen planus: A cross-sectional study

Journal of Oral Biology and Craniofacial Research
Shantala R NaikAnjani Kumar Shukla
September 11, 2020
Open Access

Direct antivirals and cognitive impairment in hepatitis C: a clinical-neurophysiologic study

Journal of Neurovirology
Gloria VaghiRoberto Cantello
September 14, 2020
Review

The effects of microglia- and astrocyte-derived factors on neurogenesis in health and disease

The European Journal of Neuroscience
Tasuku ArakiRyuta Koyama
September 16, 2020

Neuropsychological impact of trametinib in pediatric low-grade glioma: A case series

Pediatric Blood & Cancer
Rachel K PetersonLaura Janzen
September 17, 2020

Huntingtin protein maintains balanced energetics in mouse cardiomyocytes

Nucleosides, Nucleotides & Nucleic Acids
Marta TomczykRyszard T Smolenski
September 10, 2020

The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses

Psychological Medicine
Silvia AmorettiPEPs Group
September 12, 2020
Open Access

Effect of Escitalopram on Aβ levels and plaque load in an Alzheimer mouse model

Neurology
John R CirritoYvette I Sheline
September 12, 2020

"You can't touch this": delivery of inpatient neuropsychological assessment in the era of COVID-19 and beyond

The Clinical Neuropsychologist
Melissa E ParlarEmily MacKillop
September 13, 2020

Type II Cytokines Fine-Tune Thymic T Cell Selection to Offset Murine Central Nervous System Autoimmunity

The Journal of Immunology : Official Journal of the American Association of Immunologists
Subhasis BarikHabib Zaghouani
September 13, 2020
Open Access

Generation of ORIONi001-A induced pluripotent stem cell line for in vitro modeling of sporadic form of amyotrophic lateral sclerosis

Stem Cell Research
Jan StrnadelErika Halasova
September 10, 2020
Open Access

Estradiol Replacement at the Critical Period Protects Hippocampal Neural Stem Cells to Improve Cognition in APP/PS1 Mice

Frontiers in Aging Neuroscience
Yaoyao QinSha Sha
September 11, 2020
Open Access

Aging effects and test-retest reliability of inhibitory control for saccadic eye movements

ENeuro
Martyna Beata PłomeckaNicolas Langer
September 12, 2020

DNA Methylation as a Potential Molecular Mechanism in X-Linked Dystonia-Parkinsonism

Movement Disorders : Official Journal of the Movement Disorder Society
Christin KrauseHenriette Kirchner
September 15, 2020

Hashimoto encephalopathy: a case report and a short revision of current literature

Acta Bio-medica : Atenei Parmensis
Paola ChiarelloGiuseppe Raiola

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

© 2020 Meta ULC. All rights reserved
/feed-previews/stem-cells-in-neurodegenerative/eb7df63c-93a6-4753-a40e-b95572ef94b2